9th Annual School of Breast Oncologyâ„¢
|Event Date/Time: Nov 01, 2012||End Date/Time: Nov 04, 2012|
|Registration Date: Oct 31, 2012|
|Early Registration Date: Oct 01, 2012|
An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncologyâ„¢, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 4-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators. This program will also include case management sessions, question-and-answer panel discussions, and ample time for interaction with the faculty. Designed for practicing physicians at all experience levels, the School of Breast Oncologyâ„¢ provides a comprehensive overview for fellows or oncologists who are new to practice, but serves as a valuable refresher course with updates on the latest data and changes to standards of care for the oncologist who has been in practice for several years or more.
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.
Module 1: Breast Carcinogenesis and Management of High-Risk Disease
Module 2: Breast Imaging
Module 3: Breast Surgery
Module 4: Breast Radiation Therapy
Module 5: Adjuvant Chemotherapy and Endocrine Therapy
Module 6: Treatment of HER2-Positive Disease
Module 7: Systemic Treatment of Advanced/Metastatic Disease
Module 8: Organ-Targeted Treatment of Metastatic Disease
Module 9: Toxicity Management, Pregnancy, and Risk Reduction
Module 10: End of Life and Survivorship